L. Geiselhart

发表

Construction and Evaluation of a Self‐Luminescent Biosensor a

D. Holmes, M. Osgood, L. Geiselhart, 1991, Annals of the New York Academy of Sciences.

RO 31-8220, a novel protein kinase C inhibitor, inhibits early and late T cell activation events.

D. Conti, L. Geiselhart, B. Freed, 1996, Transplantation.

HLA-DR typing via LABType and the Luminex LabMAP

M. Lorber, L. Geiselhart, K. Gerolami, 2001 .

Calcium-mediated induction of anergy in the Jurkat T-cell line.

S. Gruber, D. Conti, M. Gallichio, 1994, Transplantation proceedings.

IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation1

L. Geiselhart, K. Komschlies, S. Mou, 2001, The Journal of Immunology.

The cigarette tar component p-benzoquinone blocks T-lymphocyte activation by inhibiting interleukin-2 production, but not CD25, ICAM-1, or LFA-1 expression.

F. Minnear, L. Geiselhart, B. Freed, 1997, Toxicology and applied pharmacology.

IFN- γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy Systemic administration of IL-12 and intermittent doses of IL-2

K. Nagashima, J. Wigginton, Jong-Wook Park, 2022 .

IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.

J. Wigginton, T. Back, R. Wiltrout, 2001, The Journal of clinical investigation.

Inhibition of human T lymphoblast proliferation by hydroquinone.

D. Lawrence, S. Mudzinski, Q. Li, 1996, Toxicology and applied pharmacology.